<DOC>
	<DOC>NCT00335218</DOC>
	<brief_summary>The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.</brief_summary>
	<brief_title>Fat Distribution in Healthy Early Postmenopausal Women</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Estradiol Valerate, dienogest drug combination</mesh_term>
	<criteria>Healthy early postmenopausal women BMI between 25 and 30 Contraindication(s) for hormone treatment Metabolic diseases Concomitant medication with influence on lipid metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Early postmenopausal state</keyword>
	<keyword>Climacteric symptoms</keyword>
	<keyword>Hormone replacement therapy</keyword>
</DOC>